{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:09:14Z","timestamp":1787317754601,"version":"build-2736575974"},"reference-count":29,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2015,12,23]],"date-time":"2015-12-23T00:00:00Z","timestamp":1450828800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0145666","type":"journal-article","created":{"date-parts":[[2015,12,23]],"date-time":"2015-12-23T13:45:29Z","timestamp":1450878329000},"page":"e0145666","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":14,"title":["Suppression of Rapidly Progressive Mouse Glomerulonephritis with the Non-Steroidal Mineralocorticoid Receptor Antagonist BR-4628"],"prefix":"10.1371","volume":"10","author":[{"given":"Frank Y.","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjie","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Nikolic-Paterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Kolkhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg H.","family":"Tesch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,12,23]]},"reference":[{"issue":"10","key":"ref1","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/ki.2011.48","article-title":"Mineralocorticoid receptor activation and blockade: an emerging paradigm in chronic kidney disease","volume":"79","author":"JP Bertocchio","year":"2011","journal-title":"Kidney Int"},{"issue":"5","key":"ref2","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/ajh.2011.245","article-title":"Mineralocorticoid receptor-associated hypertension and its organ damage: clinical relevance for resistant hypertension","volume":"25","author":"H Shibata","year":"2012","journal-title":"Am J Hypertens"},{"issue":"6","key":"ref3","first-page":"606","article-title":"The selective mineralocorticoid receptor antagonist eplerenone is protective in mild anti-GBM glomeru-lonephritis","volume":"4","author":"E Zitt","year":"2011","journal-title":"Int J Clin Exp Pathol"},{"key":"ref4","first-page":"8","article-title":"Aldosterone mediates glomerular inflammation in experimental mesangial proliferative glomerulonephritis","volume":"26","author":"D Qin","year":"2013","journal-title":"J Nephrol"},{"issue":"10","key":"ref5","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1681\/ASN.2012111094","article-title":"Myeloid mineralocorticoid receptor activation contributes to progressive kidney disease","volume":"25","author":"LL Huang","year":"2014","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"ref6","doi-asserted-by":"crossref","first-page":"5363","DOI":"10.1210\/en.2006-0944","article-title":"Mineralocorticoid receptor antagonist reduces renal injury in rodent models of types 1 and 2 diabetes mellitus","volume":"147","author":"C Guo","year":"2006","journal-title":"Endocrinology"},{"issue":"5","key":"ref7","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1681\/ASN.2005111196","article-title":"Spironolactone prevents diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats","volume":"17","author":"SY Han","year":"2006","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"ref8","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1093\/ndt\/gfr495","article-title":"Long-term mineralocorticoid receptor blockade ameliorates progression of experimental diabetic renal disease","volume":"27","author":"M Lian","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"ref9","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1053\/j.ajkd.2009.11.006","article-title":"Intensive versus conventional therapy to slow the progression of idiopathic glomerular diseases","volume":"55","author":"S Bianchi","year":"2010","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"ref10","doi-asserted-by":"crossref","first-page":"e26904","DOI":"10.1371\/journal.pone.0026904","article-title":"Moderate antiproteinuric effect of add-on aldosterone blockade with eplerenone in non-diabetic chronic kidney disease. A randomized cross-over study","volume":"6","author":"L Boesby","year":"2011","journal-title":"PLoS One"},{"issue":"9","key":"ref11","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.2337\/diacare.28.9.2106","article-title":"Beneficial Effects of Adding Spironolactone to Recommended Antihypertensive Treatment in Diabetic Nephropathy","volume":"28","author":"K Rossing","year":"2005","journal-title":"Diabetes Care"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s11906-013-0414-8","article-title":"Converging indications of aldosterone antagonists (spironolactone and eplerenone): a narrative review of safety profiles","volume":"16","author":"MI Danjuma","year":"2014","journal-title":"Curr Hypertens Rep"},{"issue":"3","key":"ref13","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1096\/fj.10-173286","article-title":"Mineralocorticoid receptor-mediated DNA damage in kidneys of DOCA-salt hypertensive rats","volume":"25","author":"N Schupp","year":"2011","journal-title":"FASEB J"},{"issue":"1\u20132","key":"ref14","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000335559","article-title":"Antihypertensive and cardiorenal protective effects of SM-368229, a novel mineralocorticoid receptor antagonist, in aldosterone\/salt-treated rats","volume":"89","author":"T Nariai","year":"2012","journal-title":"Pharmacology"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3389\/fphar.2013.00115","article-title":"PF-03882845, a non-steroidal mineralocorticoid receptor antagonist, prevents renal injury with reduced risk of hyperkalemia in an animal model of nephropathy","volume":"4","author":"S Orena","year":"2013","journal-title":"Frontiers in pharmacology"},{"issue":"12","key":"ref16","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1681\/ASN.V12122652","article-title":"Overexpression of brain natriuretic peptide in mice ameliorates immune-mediated renal injury","volume":"12","author":"T Suganami","year":"2001","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"ref17","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1002\/cmdc.201200081","article-title":"Discovery of BAY 94\u20138862: a nonsteroidal antagonist of the mineralocorticoid receptor for the treatment of cardiorenal diseases","volume":"7","author":"L Barfacker","year":"2012","journal-title":"ChemMedChem"},{"issue":"39","key":"ref18","doi-asserted-by":"crossref","first-page":"29932","DOI":"10.1074\/jbc.M110.131342","article-title":"A new mode of mineralocorticoid receptor antagonism by a potent and selective nonsteroidal molecule","volume":"285","author":"J Fagart","year":"2010","journal-title":"J Biol Chem"},{"issue":"9","key":"ref19","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1007\/s00125-014-3291-z","article-title":"Deletion of bone-marrow-derived receptor for AGEs (RAGE) improves renal function in an experimental mouse model of diabetes","volume":"57","author":"G Tesch","year":"2014","journal-title":"Diabetologia"},{"issue":"10","key":"ref20","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1210\/me.2004-0529","article-title":"A Nuclear Receptor Atlas: macrophage activation","volume":"19","author":"GD Barish","year":"2005","journal-title":"Molecular endocrinology"},{"key":"ref21","first-page":"1511","article-title":"Diseases of the Kidney and Urinary Tract","author":"PG Kerr","year":"2007"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"R5","DOI":"10.1186\/ar2353","article-title":"The role of aldosterone blockade in murine lupus nephritis","volume":"10","author":"SU Monrad","year":"2008","journal-title":"Arthritis research & therapy"},{"issue":"20","key":"ref23","doi-asserted-by":"crossref","first-page":"3654","DOI":"10.1016\/j.yexcr.2008.09.018","article-title":"Aldosterone induces myofibroblastic transdifferentiation and collagen gene expression through the Rho-kinase dependent signaling pathway in rat mesangial cells","volume":"314","author":"S Diah","year":"2008","journal-title":"Exp Cell Res"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.bbrc.2006.07.057","article-title":"Aldosterone promotes fibronectin production through a Smad2-dependent TGF-beta1 pathway in mesangial cells","volume":"348","author":"L Lai","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"ref25","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1161\/01.HYP.0000174593.88899.68","article-title":"Aldosterone stimulates collagen gene expression and synthesis via activation of ERK1\/2 in rat renal fibroblasts","volume":"46","author":"Y Nagai","year":"2005","journal-title":"Hypertension"},{"issue":"1","key":"ref26","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.gene.2013.08.047","article-title":"Aldosterone stimulates fibronectin synthesis in renal fibroblasts through mineralocorticoid receptor-dependent and independent mechanisms","volume":"531","author":"D Chen","year":"2013","journal-title":"Gene"},{"issue":"6","key":"ref27","doi-asserted-by":"crossref","first-page":"F1323","DOI":"10.1152\/ajprenal.90428.2008","article-title":"Aldosterone-induced mesangial cell proliferation is mediated by EGF receptor transactivation","volume":"296","author":"S Huang","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"issue":"4","key":"ref28","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.1159\/000339500","article-title":"Aldosterone induces kidney fibroblast proliferation via activation of growth factor receptors and PI3K\/MAPK signalling","volume":"120","author":"LL Huang","year":"2012","journal-title":"Nephron Exp Nephrol"},{"issue":"5","key":"ref29","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1046\/j.1523-1755.2003.00929.x","article-title":"Aldosterone\/salt induces renal inflammation and fibrosis in hypertensive rats","volume":"63","author":"ER Blasi","year":"2003","journal-title":"Kidney Int"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0145666","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,30]],"date-time":"2022-05-30T12:25:33Z","timestamp":1653913533000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0145666"}},"subtitle":[],"editor":[{"given":"Jeff M","family":"Sands","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,12,23]]},"references-count":29,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2015,12,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0145666","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,23]]}}}